Press Releases

Given the unfair aspects of CVS’s arbitration clause, delegating to an arbitrator to decide whether the case has to be arbitrated is “unconscionable,” says federal judge

Making America Healthy Again should start with PBM reform

Camber Pharmaceuticals is proud to expand its product line with Quetiapine Tablets, USP, offering patients a more affordable, high-quality treatment option.

Camber is the first and only generic option for Gastrografin®.

This marks India’s first trial for a novel autologous BCMA directed CAR-T cell therapy in patients with relapsed/refractory multiple myeloma.

CMS’ failure to require timely, sufficient pharmacy reimbursement will lead to closures not seen since the start of Part D and patients will suffer as a result.

With a scalable, flexible suite of services and an experienced leadership team, InspiroGene enables manufacturers, payers, and providers to navigate the complex CGT commercialization landscape to ensure patients can access the life-changing treatments they need.

Camber is fully prepared for DSCSA compliance by November 2024.

Thrifty White Health receives the Innovation Award

Eszopiclone Tablets, USP are indicated for the treatment of insomnia.

Pilot Will Evaluate Measure Concepts and Data Exchange in Value-Based Arrangements

Pharmacists receive 3 years of funding to improve medication safety for homeless and unhoused community members

Rebates increase drug prices, says NCPA